Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Tabuse, Masanao ^a   Ohta, Shigeki ^a   Ohashi, Yohei ^a   Fukaya, Raita ^a   Misawa, Aya ^a   Yoshida, Kazunari ^a   Kawase, Takeshi ^a   Saya, Hideyuki ^a   Thirant, Cécile ^b   Chneiweiss, Hérve ^b   Matsuzaki, Yumi ^a   Okano, Hideyuki ^a   Kawakami, Yutaka ^a   Toda, Masahiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXD9; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; HOXD9 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; ASTROCYTE; ASTROCYTOMA; CANCER CELL CULTURE; CANCER STEM CELL; CANCER TISSUE; CELL CYCLE ARREST; CELL FRACTIONATION; CELL PROLIFERATION; CELL SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; NEURAL STEM CELL; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; BRAIN TUMOR; CELL STRAIN HEK293; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TUMOR CELL LINE;

APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GLIOMA; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS;

EID: 79956226600     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-60     Document Type: Article

References (50)

1. Benjamin R, Capparella J, Brown A. Classification of glioblastoma multiforme in adults by molecular genetics. Cancer J 2003, 9:82-90. 10.1097/00130404-200303000-00003, 12784873.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996. 10.1056/NEJMoa043330, 15758009.
3. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111. 10.1038/35102167, 11689955.
4. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer 2006, 6:425-436. 10.1038/nrc1889, 16723989.
5. Stiles CD, Rowitch DH. Glioma stem cells: a midterm exam. Neuron 2008, 58:832-846. 10.1016/j.neuron.2008.05.031, 18579075.
6. Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, Ravetti GL, Zona GL, Daga A, Corte G. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 2009, 27:40-48. 10.1634/stemcells.2008-0493, 18948646.
7. Thon N, Damianoff K, Hegermann J, Grau S, Krebs B, Schnell O, Tonn JC, Goldbrunner R. Presence of pluripotent CD133(+) cells correlates with malignancy of gliomas. Mol Cell Neurosci 2010, 43:51-59. 10.1016/j.mcn.2008.07.022, 18761091.
8. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828.
9. Son MJ, Woolard K, Nam DH, Lee J, Fine HA. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 2009, 4:440-452. 10.1016/j.stem.2009.03.003, 19427293.
10. Patru C, Romao L, Varlet P, Coulombel L, Raponi E, Cadusseau J, Renault-Mihara F, Thirant C, Leonard N, Bernheim A, et al. CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors. BMC Cancer 2010, 10:66. 10.1186/1471-2407-10-66, 2841664, 20181261.
11. Prestegarden L, Enger PO. Cancer Stem Cells in the Central Nervous System - A Critical Review. Cancer Res 2010, 70:8255-8258. 10.1158/0008-5472.CAN-10-1592, 20959482.
12. Doboule D. Guidebook to the Homeobox Genes 1994, New York: Oxford Univ. Press.
13. Carroll SB. Homeotic genes and the evolution of arthropods and chordates. Nature 1995, 376:479-485. 10.1038/376479a0, 7637779.
14. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer 2010, 10:361-371. 10.1038/nrc2826, 20357775.
15. Barber BA, Rastegar M. Epigenetic control of Hox genes during neurogenesis, development, and disease. Ann Anat 2010, 192:261-274. 10.1016/j.aanat.2010.07.009, 20739155.
16. Ohashi Y, Ueda M, Kawase T, Kawakami Y, Toda M. Identification of an epigenetically silenced gene, RFX1, in human glioma cells using restriction landmark genomic scanning. Oncogene 2004, 23:7772-7779. 10.1038/sj.onc.1208058, 15334059.
17. Fromental-Ramain C, Warot X, Lakkaraju S, Favier B, Haack H, Birling C, Dierich A, Dollé P, Chambon P. Specific and redundant functions of the paralogous Hoxa-9 and Hoxd-9 genes in forelimb and axial skeleton patterning. Development 1996, 122:461-472.
18. Morgan BA, Tabin C. Hox genes and growth: early and late roles in limb bud morphogenesis. Dev Suppl 1994, 181-186.
19. Abdel-Fattah R, Xiao A, Bomgardner D, Pease CS, Lopes MB, Hussaini IM. Differential expression of HOX genes in neoplastic and non-neoplastic human astrocytes. J Pathol 2006, 209:15-24. 10.1002/path.1939, 16463268.
20. Buccoliero AM, Castiglione F, Degl'Innocenti DR, Ammanati F, Giordano F, Sanzo M, Mussa F, Genitori L, Taddei GL. Hox-D genes expression in pediatric low-grade gliomas: real-time-PCR study. Cell Mol Neurobiol 2009, 29:1-6. 10.1007/s10571-008-9282-1, 18404365.
21. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002, 61:215-225. discussion 226-219.
22. Fukaya R, Ohta S, Yamaguchi M, Fujii H, Kawakami Y, Kawase T, Toda M. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1. Cancer Lett 2009, 291(2):150-7.
23. Hattori Y, Ohta S, Hamada K, Yamada-Okabe H, Kanemura Y, Matsuzaki Y, Okano H, Kawakami Y, Toda M. Identification of a neuron-specific human gene, KIAA1110, that is a guanine nucleotide exchange factor for ARF1. Biochem Biophys Res Commun 2007, 364:737-742. 10.1016/j.bbrc.2007.10.041, 17981261.
24. Brown JE, Dunmore SJ. Leptin decreases apoptosis and alters BCL-2: Bax ratio in clonal rodent pancreatic beta-cells. Diabetes Metab Res Rev 2007, 23:497-502. 10.1002/dmrr.726, 17318810.
25. Williams NS, Gaynor RB, Scoggin S, Verma U, Gokaslan T, Simmang C, Fleming J, Tavana D, Frenkel E, Becerra C. Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 2003, 9:931-946.
26. Roth RB, Hevezi P, Lee J, Willhite D, Lechner SM, Foster AC, Zlotnik A. Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. Neurogenetics 2006, 7:67-80. 10.1007/s10048-006-0032-6, 16572319.
27. Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J, et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 2008, 3:e3088. 10.1371/journal.pone.0003088, 2518524, 18769486.
28. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006, 9:287-300. 10.1016/j.ccr.2006.03.003, 16616334.
29. Nitta M, Kobayashi O, Honda S, Hirota T, Kuninaka S, Marumoto T, Ushio Y, Saya H. Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents. Oncogene 2004, 23:6548-6558. 10.1038/sj.onc.1207873, 15221012.
30. Hetschko H, Voss V, Horn S, Seifert V, Prehn JH, Kogel D. Pharmacological inhibition of Bcl-2 family members reactivates TRAIL-induced apoptosis in malignant glioma. J Neurooncol 2008, 86:265-272. 10.1007/s11060-007-9472-6, 17924059.
31. Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K, Miyazono K. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 2009, 5:504-514. 10.1016/j.stem.2009.08.018, 19896441.
32. Kanemura Y, Mori H, Kobayashi S, Islam O, Kodama E, Yamamoto A, Nakanishi Y, Arita N, Yamasaki M, Okano H, et al. Evaluation of in vitro proliferative activity of human fetal neural stem/progenitor cells using indirect measurements of viable cells based on cellular metabolic activity. J Neurosci Res 2002, 69:869-879. 10.1002/jnr.10377, 12205680.
33. Ishikawa S, Ito K. Plasticity and regulatory mechanisms of Hox gene expression in mouse neural crest cells. Cell Tissue Res 2009, 337:381-391. 10.1007/s00441-009-0827-5, 19585150.
34. Radisky DC. Defining a role for the homeoprotein Six1 in EMT and mammary tumorigenesis. J Clin Invest 2009, 119:2528-2531. 10.1172/JCI40555, 2735897, 19726879.
35. Mohankumar KM, Perry JK, Kannan N, Kohno K, Gluckman PD, Emerald BS, Lobie PE. Transcriptional activation of signal transducer and activator of transcription (STAT) 3 and STAT5B partially mediate homeobox A1-stimulated oncogenic transformation of the immortalized human mammary epithelial cell. Endocrinology 2008, 149:2219-2229. 10.1210/en.2007-1320, 18276758.
36. Bendall AJ, Ding J, Hu G, Shen MM, Abate-Shen C. Msx1 antagonizes the myogenic activity of Pax3 in migrating limb muscle precursors. Development 1999, 126:4965-4976.
37. Gao N, White P, Kaestner KH. Establishment of intestinal identity and epithelial-mesenchymal signaling by Cdx2. Dev Cell 2009, 16:588-599. 10.1016/j.devcel.2009.02.010, 2673200, 19386267.
38. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, Chang HY. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323. 10.1016/j.cell.2007.05.022, 2084369, 17604720.
39. Woo CJ, Kharchenko PV, Daheron L, Park PJ, Kingston RE. A region of the human HOXD cluster that confers polycomb-group responsiveness. Cell 2010, 140:99-110. 10.1016/j.cell.2009.12.022, 20085705.
40. Flagiello D, Poupon MF, Cillo C, Dutrillaux B, Malfoy B. Relationship between DNA methylation and gene expression of the HOXB gene cluster in small cell lung cancers. FEBS Lett 1996, 380:103-107. 10.1016/0014-5793(96)00017-8, 8603715.
41. Wu X, Rauch TA, Zhong X, Bennett WP, Latif F, Krex D, Pfeifer GP. CpG island hypermethylation in human astrocytomas. Cancer Res 2010, 70:2718-2727. 10.1158/0008-5472.CAN-09-3631, 2848870, 20233874.
42. Nguyen NC, Hirose T, Nakazawa M, Kobata T, Nakamura H, Nishioka K, Nakajima T. Expression of HOXD9 in fibroblast-like synoviocytes from rheumatoid arthritis patients. Int J Mol Med 2002, 10:41-48.
43. Liu DB, Gu ZD, Cao XZ, Liu H, Li JY. Immunocytochemical detection of HoxD9 and Pbx1 homeodomain protein expression in Chinese esophageal squamous cell carcinomas. World J Gastroenterol 2005, 11:1562-1566.
44. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates JR, Nusse R. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003, 423:448-452. 10.1038/nature01611, 12717451.
45. Garcia-Castro MI, Marcelle C, Bronner-Fraser M. Ectodermal Wnt function as a neural crest inducer. Science 2002, 297:848-851.
46. Gouti M, Gavalas A. Hoxb1 controls cell fate specification and proliferative capacity of neural stem and progenitor cells. Stem Cells 2008, 26:1985-1997. 10.1634/stemcells.2008-0182, 18499896.
47. Lu SJ, Feng Q, Ivanova Y, Luo C, Li T, Li F, Honig GR, Lanza R. Recombinant HoxB4 fusion proteins enhance hematopoietic differentiation of human embryonic stem cells. Stem Cells Dev 2007, 16:547-559. 10.1089/scd.2007.0002, 17784829.
48. Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 2009, 8:806-823. 10.1038/nrd2137, 19794444.
49. Costa BM, Smith JS, Chen Y, Chen J, Phillips HS, Aldape KD, Zardo G, Nigro J, James CD, Fridlyand J, et al. Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma. Cancer Res 2010, 70:453-462. 10.1158/0008-5472.CAN-09-2189, 2849935, 20068170.
50. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou MF, de Tribolet N, Regli L, Wick W, Kouwenhoven MC, et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 2008, 26:3015-3024. 10.1200/JCO.2007.15.7164, 18565887.